상단으로
Contact Us

Not Available for sale in the United States

  • Real-time
    PCR
  • Research
    Use Only

Novaplex™
SARS-CoV-2 Variants VII Assay

Identification of Omicron specific mutation for variant surveillance

Key Features and Benefits

  • Omicron confirmation test

    - Targeting three Omicron-related mutations
    - A fast solution in response to the rapid spreading of Omicron

  • SARS-CoV-2 primaray screening

    - RdRP mutation as a marker of SARS-CoV-2
    - Provides the result of SARS-CoV-2 infection

  • Reliable test result

    - High sensitivity; 50 RNA copies/rxn
    - Detects Omicron specific mutation - E484A

  • Short TAT

    Results within 2 hours after extraction

  • Whole process validation

    Whole process validation from extraction to PCR by whole process control

  • User-friendly workflow

    Convenient workflow using Seegene's automated one streamlined system

  • Automatic data analyzer

    Automated data interpretation and LIS interlocking with Seegene Viewer

  • Analytes

    Novaplex™
    SARS-CoV-2 Variants VII Assay

    • E484A (S gene)
    • HV69/70 deletion (S gene)
    • N501Y (S gene)
    • SARS-CoV-2 (RdRP gene)
    • Internal Control (IC)
  • Specimens

    • Nasopharyngeal swab
    • Nasopharyngeal aspirate
    • Bronchoalveolar lavage
    • Sputum [1]
    • Oropharyngeal swab
    • Saliva
  • Ordering Information

    Product
    Cat No. / Size
    Novaplex™ SARS-CoV-2 Variants VII Assay
    R-RV10360W / 124 rxns

Result


Note

[1] not applicable on NIMBUS IVD & STARTlet IVD